Stasis and poisonous Conghua - cardio-cerebral vascular thrombotic disease etiology and pathogenesis.docVIP

 PAGE \* MERGEFORMAT 26 Stasis and poisonous Conghua - cardio-cerebral vascular thrombotic disease etiology and pathogenesis Author: Da-Zhuo Shi, Xu Hao, YIN Hui-jun, Zhang Jing-chun, Chen Ke-ji Abstract cardio-cerebral vascular thrombotic diseases in the process of platelet activation, adhesion, aggregation and thrombosis, traditional Chinese medicine in many of its etiology and pathogenesis attributed to “blood stasis” aspect; but tissue necrosis, oxidative stress had injury, inflammation and other pathological changes, far from the single “blood stasis” cause can be summarized. According to traditional Chinese medicine “poisonous” evil understanding of the cause, cardiovascular and cerebrovascular thrombotic diseases when there is “poison” evil disease, or “stasis” and “poisonous” Conghua the cause of inter-node disease pathogenesis. Focus on “stasis” and “poisonous” cause of heart disease, cerebral vascular thrombosis in the pathogenesis of the mutual and folders, each Conghua, and explore the treatment method Prescriptions for a rich heart disease, cerebral vascular thrombosis TCM etiology, improve the clinical efficacy, with a significance. Keywords: cardiovascular disease; thrombosis; blood stasis Abstract: According to the basic theory of traditional Chinese medicine (TCM), the pathogenetic factors such as platelet activation, adhesion, congregation and thrombosis fall into the category of blood stasis, while the pathological changes such as tissue necrosis, oxidative stress injury and inflammation , etc, are far beyond the etiological category of blood stasis. The toxin or the combination and transformation of toxin and blood stasis of TCM are involved in the pathogenesis of thrombotic cerebrocardiovascualr diseases. It is significant to recognize and stress the combination and transformation of toxin and stasis in pathogenicity so as to enrich TCM etiology and improve TCM clinical efficacy in the treatment of cerebrocardiova